Skip to main content

BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Expands C-Suite to Welcome Key GBB Drink Lab Execs

Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness, today announced that, along with the asset purchase agreement for the company’s purchased and provisional patents, two GBB Drink Lab executives will join Jupiter Wellness’ C-suite. Josh Wagner, the former U.S. director of sales for Anheuser Busch, where he led a $12 billion business with a 72 person sales team to their best performance since 2009, will serve as Jupiter Wellness’ chief revenue officer. In addition, David Sandler, the former COO and CSO of several supplement brands that exceeded $75 million in revenue, will serve as the company’s chief operating officer. “We welcome Josh and David on board as we prepare to aggressively launch a product that has shown great early results,” said Jupiter Wellness CEO Brian John, speaking of the company’s plans to bring “Safety Shot” to market. “We have also had a few people that reported feeling more clear-minded and focused after consuming 4oz of the drink without the presence of alcohol. I look forward to performing more trials on the drink to show its true potential.”

To view the full press release, visit

About Jupiter Wellness Inc.

Jupiter Wellness, a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sells its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands Inc. Jupiter Wellness Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida. For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.